M Trademark

Trademark Overview

On Monday, February 20, 2017, a trademark application was filed for M with the United States Patent and Trademark Office. The USPTO has given the M trademark a serial number of 87341980. The federal status of this trademark filing is REGISTERED as of Tuesday, March 30, 2021. This trademark is owned by Milla Pharmaceuticals, Inc.. The M trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for prevention and correction of metabolic acidosis, prevention and treatment of hyponatremia, use as an additive for preparing intravenous fluid formulas, prevention and control of seizures in preeclampsia and eclampsia, and for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes
m

General Information

Serial Number87341980
Word MarkM
Filing DateMonday, February 20, 2017
Status700 - REGISTERED
Status DateTuesday, March 30, 2021
Registration Number6309150
Registration DateTuesday, March 30, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 1, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a stylized "M" inside a circle.
Goods and ServicesPharmaceutical preparations for prevention and correction of metabolic acidosis, prevention and treatment of hyponatremia, use as an additive for preparing intravenous fluid formulas, prevention and control of seizures in preeclampsia and eclampsia, and for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 27, 2017
Primary Code005
First Use Anywhere DateFriday, April 24, 2020
First Use In Commerce DateFriday, April 24, 2020

Trademark Owner History

Party NameMilla Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMinnetonka, MN 55305
US
Party NameMilla Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMinnetonka, MN 55305
US
Party NameMilla Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMinnetonka, MN 55305
US

Trademark Events

Event DateEvent Description
Thursday, February 23, 2017NEW APPLICATION ENTERED
Monday, February 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 28, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, May 16, 2017ASSIGNED TO EXAMINER
Tuesday, May 16, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 16, 2017NON-FINAL ACTION E-MAILED
Tuesday, May 16, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 14, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 1, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 5, 2018SOU TEAS EXTENSION RECEIVED
Monday, March 5, 2018SOU EXTENSION 1 FILED
Monday, March 5, 2018SOU EXTENSION 1 GRANTED
Wednesday, March 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 24, 2018SOU TEAS EXTENSION RECEIVED
Monday, September 24, 2018SOU EXTENSION 2 FILED
Monday, September 24, 2018SOU EXTENSION 2 GRANTED
Wednesday, September 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 3, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 3, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 5, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2019SOU EXTENSION 3 FILED
Tuesday, March 5, 2019SOU EXTENSION 3 GRANTED
Thursday, March 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019SOU EXTENSION 4 FILED
Tuesday, September 3, 2019SOU EXTENSION 4 GRANTED
Thursday, September 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 17, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, January 22, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 17, 2020SOU EXTENSION 5 FILED
Wednesday, January 22, 2020SOU EXTENSION 5 GRANTED
Thursday, January 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 13, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, May 13, 2020USE AMENDMENT FILED
Tuesday, May 19, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 28, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, May 28, 2020NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 18, 2021ASSIGNED TO LIE
Friday, February 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 23, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 24, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 30, 2021REGISTERED-PRINCIPAL REGISTER
Friday, April 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 30, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 31, 2026TEAS SECTION 8 & 15 RECEIVED

Related Keywords

prevention treatment acute migraine eclampsia preeclampsia headaches without headache cluster